Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Oncolytics Biotech, Inc’s current trading price is -33.33% away from its 52-week high, while its distance from the 52-week low is 213.08%. The stock’s price range over this period has fluctuated between $0.33 and $1.53. The company, operating within the financial sector, had a trading volume of approximately 1.36 million for the day, which was noticeably higher than the average daily share volume of 1.21 million over the last 3 months.
Oncolytics Biotech, Inc (ONCY) stock is currently valued at $1.02. During the last session, the stock experienced a remarkable rise, reaching $7.0 after opening at $1.02. The stock briefly dropped to $3.0 before ultimately closing at $0.86.
In terms of market performance, Oncolytics Biotech, Inc had a fairly even. The highest value for the stock in the past year was $1.53 on 10/07/24, and the lowest value was recorded at $0.33 on 06/06/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Oncolytics Biotech, Inc (ONCY) has experienced a quarterly rise of 91.01% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 98.53M and boasts a workforce of 28 employees.
Oncolytics Biotech, Inc: What Analysts Are Saying
As of right now, 2 analysts are rating Oncolytics Biotech, Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6978, with a change in price of +0.3936. Similarly, Oncolytics Biotech, Inc recorded 882,377 in trading volume during the last 100 days, posting a change of +62.84%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ONCY stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.10.
ONCY Stock Stochastic Average
Today, Oncolytics Biotech, Inc’s raw stochastic average for the past 50 days stands at 67.78%, indicating a rise from the raw stochastic average of the last 20 days, which was 40.00%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 21.08% and 15.66% respectively.
ONCY Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded an increase of 5.13%. However, over the last six months, the performance has been weaker by 34.99%. The price of ONCY decreased -9.73% over the last 30 days. And in the last five days, it has surged by 9.68%.
